News
-
-
COMMUNIQUÉ DE PRESSE
Aumann achieves 17% revenue and 86% EBITDA growth in the first nine months and strengthens growth areas outside the automotive industry
Aumann AG achieves 17% revenue and 86% EBITDA growth in the first nine months of 2024 and focuses on growth areas outside the automotive industry. Read the full quarterly statement at www.aumann.com -
-
-
-
COMMUNIQUÉ DE PRESSE
PharmaSGP with strong revenues growth in 9M 2024 – revenues forecast for FY 2024 raised
PharmaSGP Holding SE reports strong revenue growth in 9 months of 2024, with preliminary figures showing a 17.0% increase compared to the same period last year. FY 2024 revenue forecast raised -
-
-
COMMUNIQUÉ DE PRESSE
adesso shows stronger profitability in the third quarter and increases operating result after nine months by 24 % to EUR 66.5 million / Sales revenues grow by 15 % to EUR 961.3 million
adesso SE reports 24% increase in operating result after nine months to EUR 66.5 million, with sales revenues growing by 15% to EUR 961.3 million, driven by strong demand for digitalisation services -
COMMUNIQUÉ DE PRESSE
Dermapharm Holding SE posts strong results for Q3 2024, Arkopharma (France) back above prior-year EBITDA levels for first time
Dermapharm Holding SE reports strong Q3 2024 results with consolidated revenue up 2.7% to EUR 890.1 million. Adjusted EBITDA margin improves. Outlook confirms forecasted targets for 2024
